Cargando…

A tissue engineering strategy for the treatment of avascular necrosis of the femoral head

BACKGROUND & PURPOSE: Skeletal stem cells (SSCs) and impaction bone grafting (IBG) can be combined to produce a mechanically stable living bone composite. This novel strategy has been translated to the treatment of avascular necrosis of the femoral head. Surgical technique, clinical follow-up an...

Descripción completa

Detalles Bibliográficos
Autores principales: Aarvold, A., Smith, J.O., Tayton, E.R., Jones, A.M.H., Dawson, J.I., Lanham, S., Briscoe, A., Dunlop, D.G., Oreffo, R.O.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Publications Office, The Royal College of Surgeons of Edinburgh 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989057/
https://www.ncbi.nlm.nih.gov/pubmed/23540814
http://dx.doi.org/10.1016/j.surge.2013.02.008
_version_ 1782312114029854720
author Aarvold, A.
Smith, J.O.
Tayton, E.R.
Jones, A.M.H.
Dawson, J.I.
Lanham, S.
Briscoe, A.
Dunlop, D.G.
Oreffo, R.O.C.
author_facet Aarvold, A.
Smith, J.O.
Tayton, E.R.
Jones, A.M.H.
Dawson, J.I.
Lanham, S.
Briscoe, A.
Dunlop, D.G.
Oreffo, R.O.C.
author_sort Aarvold, A.
collection PubMed
description BACKGROUND & PURPOSE: Skeletal stem cells (SSCs) and impaction bone grafting (IBG) can be combined to produce a mechanically stable living bone composite. This novel strategy has been translated to the treatment of avascular necrosis of the femoral head. Surgical technique, clinical follow-up and retrieval analysis data of this translational case series is presented. METHODS: SSCs and milled allograft were impacted into necrotic bone in five femoral heads of four patients. Cell viability was confirmed by parallel in vitro culture of the cell-graft constructs. Patient follow-up was by serial clinical and radiological examination. Tissue engineered bone was retrieved from two retrieved femoral heads and was analysed by histology, microcomputed tomography (μCT) and mechanical testing. RESULTS: Three patients remain asymptomatic at 22- to 44-month follow-up. One patient (both hips) required total hip replacement due to widespread residual necrosis. Retrieved tissue engineered bone demonstrated a mature trabecular micro-architecture histologically and on μCT. Bone density and axial compression strength were comparable to trabecular bone. CONCLUSIONS: Clinical follow-up shows this to be an effective new treatment for focal early stage avascular necrosis of the femoral head. Unique retrieval analysis of clinically translated tissue engineered bone has demonstrated regeneration of tissue that is both structurally and functionally analogous to normal trabecular bone.
format Online
Article
Text
id pubmed-3989057
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Publications Office, The Royal College of Surgeons of Edinburgh
record_format MEDLINE/PubMed
spelling pubmed-39890572014-04-17 A tissue engineering strategy for the treatment of avascular necrosis of the femoral head Aarvold, A. Smith, J.O. Tayton, E.R. Jones, A.M.H. Dawson, J.I. Lanham, S. Briscoe, A. Dunlop, D.G. Oreffo, R.O.C. Surgeon Article BACKGROUND & PURPOSE: Skeletal stem cells (SSCs) and impaction bone grafting (IBG) can be combined to produce a mechanically stable living bone composite. This novel strategy has been translated to the treatment of avascular necrosis of the femoral head. Surgical technique, clinical follow-up and retrieval analysis data of this translational case series is presented. METHODS: SSCs and milled allograft were impacted into necrotic bone in five femoral heads of four patients. Cell viability was confirmed by parallel in vitro culture of the cell-graft constructs. Patient follow-up was by serial clinical and radiological examination. Tissue engineered bone was retrieved from two retrieved femoral heads and was analysed by histology, microcomputed tomography (μCT) and mechanical testing. RESULTS: Three patients remain asymptomatic at 22- to 44-month follow-up. One patient (both hips) required total hip replacement due to widespread residual necrosis. Retrieved tissue engineered bone demonstrated a mature trabecular micro-architecture histologically and on μCT. Bone density and axial compression strength were comparable to trabecular bone. CONCLUSIONS: Clinical follow-up shows this to be an effective new treatment for focal early stage avascular necrosis of the femoral head. Unique retrieval analysis of clinically translated tissue engineered bone has demonstrated regeneration of tissue that is both structurally and functionally analogous to normal trabecular bone. Publications Office, The Royal College of Surgeons of Edinburgh 2013-12 /pmc/articles/PMC3989057/ /pubmed/23540814 http://dx.doi.org/10.1016/j.surge.2013.02.008 Text en © 2013 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Aarvold, A.
Smith, J.O.
Tayton, E.R.
Jones, A.M.H.
Dawson, J.I.
Lanham, S.
Briscoe, A.
Dunlop, D.G.
Oreffo, R.O.C.
A tissue engineering strategy for the treatment of avascular necrosis of the femoral head
title A tissue engineering strategy for the treatment of avascular necrosis of the femoral head
title_full A tissue engineering strategy for the treatment of avascular necrosis of the femoral head
title_fullStr A tissue engineering strategy for the treatment of avascular necrosis of the femoral head
title_full_unstemmed A tissue engineering strategy for the treatment of avascular necrosis of the femoral head
title_short A tissue engineering strategy for the treatment of avascular necrosis of the femoral head
title_sort tissue engineering strategy for the treatment of avascular necrosis of the femoral head
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989057/
https://www.ncbi.nlm.nih.gov/pubmed/23540814
http://dx.doi.org/10.1016/j.surge.2013.02.008
work_keys_str_mv AT aarvolda atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT smithjo atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT taytoner atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT jonesamh atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT dawsonji atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT lanhams atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT briscoea atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT dunlopdg atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT orefforoc atissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT aarvolda tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT smithjo tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT taytoner tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT jonesamh tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT dawsonji tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT lanhams tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT briscoea tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT dunlopdg tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead
AT orefforoc tissueengineeringstrategyforthetreatmentofavascularnecrosisofthefemoralhead